Michael Schönhofen

Corporate Officer/Principal en

Fresenius Kabi AG

65 años

18 relaciones

Health Technology

Consumer Services

Commercial Services

Perfil

Michael Schönhofen is currently the President-Biopharma at Fresenius Kabi AG.
Previously, he worked as a Non-Executive Director at Fresenius Kabi Oncology Ltd. from 2008 to 2023.
He holds a doctorate degree from Technische Universität Darmstadt.

Cargos activos de Michael Schönhofen

Empresas	Cargo	Inicio
Fresenius Kabi AG Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Corporate Officer/Principal	-

Todos los cargos activos de Michael Schönhofen

Antiguos cargos conocidos de Michael Schönhofen.

Empresas	Cargo	Fin
FRESENIUS KABI ONCOLOGY LTD	Director Técnico/Científico/I+D	13/01/2010

Ver el detalle de la experiencia de Michael Schönhofen.

Formación de Michael Schönhofen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Schönhofen.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Fresenius Kabi AG Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases	Health Technology
Technische Universität Darmstadt Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fresenius Kabi Oncology Ltd. Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures and markets cancer research and anticancer products	Commercial Services